Perfuse Therapeutics

0 followers


Perfuse Therapeutics is a seed-stage company pursuing a novel mechanism to improve retinal perfusion in the context of various retinal diseases starting with glaucoma

Industries

Headquarters

Stage

Employees

Links

Org chart

Andrew Melie
Analytical Scientist
Christopher Romeo
Senior Scientist
Heather Schmitt
Pharmacology Senior Scientist
Maria Zaretskaia, M.D.
Principal Scientist
Karen Brennan
Senior Director, Preclinical And CMC Analytical Development
Phillip Lai
Chief Medical Officer
Angela Glendenning
Senior Director Formulation Development And Manufacturing